Skip to main content
SpringerLink
Log in

Erkrankungen von Niere und Urogenitaltrakt

  • Chapter
Medizinische Therapie in Klinik und Praxis

  • 96 Accesses

Zusammenfassung

Das akute Nierenversagen (ANV) ist ein klinisches Syndrom, das durch die abrupte, meist reversible Einschränkung der exkretorischen Nierenfunktion gekennzeichnet ist, die zur Akkumulation von Stoffwechselendprodukten und Störungen des Wasser-, Elektrolyt- und Säuren-Basen-Haushaltes führt. Das ANV geht häufig mit einer Oligurie einher (oligurisches Nierenversagen), kann aber in vielen Fällen mit einer nicht beeinträchtigten Flüssigkeitsausscheidung verlaufen (nichtoligurisches ANV).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Brezis M, Rosen S (1995) Hypoxia of the renal medulla–its implications for disease. N Engl J Med 332: 647–655

    Article  PubMed  CAS  Google Scholar 

  • Druml W, Lax F, Grimm G, Schneeweiß B, Lenz K, Laggner AN (1994) Acute renal failure in the elderly: 1975–1990. Clin Nephrol 41: 342–349

    PubMed  CAS  Google Scholar 

  • Druml W (1998) Metabolic perturbations in patients with acute renal failure. In: Ronco C, Bellomo R (eds) Critical care nephrology, Kluwer Academic Publishers, Dordrecht,pp 831–838

    Chapter  Google Scholar 

  • Druml W (1999) Metabolic effects of continuous renal replacement therapies. Kidney Int 56 [Suppl]:S-56-S-61

    Google Scholar 

  • Druml W (2001) Nutritional support in patients with acute renal failure. In: Molitoris BA, Finn WF (eds) Acute renal failure. WB Saunders, Philadelphia, pp 465–489

    Google Scholar 

  • Herbert MK, Druml W (2000) Pharmacologic therapy of acute renal failure. A clinical point of view. Curr Opinion Cardiovasc Pulmon Renal Investigat Drugs 2: 345–353

    Google Scholar 

  • Lassnig D, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M (2000) Lack of renoprotective effects of dopamin and furosemide during cardiac surgery. J Am Soc Nephrol 11: 97–104

    Google Scholar 

  • Molitoris BA, Finn WF (eds) (2001) Acute renal failure. WB Saunders, Philadelphia

    Google Scholar 

  • Casadevall N, Nataf J, Viron B et al. (2002) Pure red-cell aplasia and anti-erythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346: 469–475

    Article  PubMed  CAS  Google Scholar 

  • European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure (1999) Nephrol Dial Transplant 14 (Suppl 5): 1–50

    Google Scholar 

  • Gershon SK, Luksenburg H, Coté TR, Braun MM (2000) Pure red-cell aplasia and recombinant erythropoietin (letter). N Engl J Med 346: 1584–1585

    Google Scholar 

  • Guideline 1 (2002) Definition and stages of chronic kidney disease. Am J Kidney Dis 39 (Suppl 1): S46 - S75

    Google Scholar 

  • Guideline 5 (2002) Assessment of proteinuria. Am J Kidney Dis 39 (Suppl 1): S93 - S104

    Google Scholar 

  • Guideline 9 (2002) Association of level of GFR with nutritional status. Am J Kidney Dis 39 (Suppl 1): S128 - S142

    Google Scholar 

  • Guideline (2002) Association of level of GFR with bone disease and disorders of calcium and phosphorus metabolism. Am J Kidney Dis 39 (Suppl 1): S143 - S155

    Google Scholar 

  • Guideline (2002) Association of level of GFR with neuropathy. Am J Kidney Dis 39 (Suppl 1): S156–5160

    Google Scholar 

  • Guideline (2002) Association of level of GFR with indices of functioning and well-being. Am J Kidney Dis 39 (Suppl 1): S161 - S168

    Google Scholar 

  • Guideline (1995) Factors associated with loss of kidney function in chronic kidney disease. Am J Kidney Dis 39 (Suppl 1): 5170–5212

    Google Scholar 

  • Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM (1995) Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6: 1386–1391

    PubMed  CAS  Google Scholar 

  • Levin A, Thompson CR, Ethier J et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34: 125–134

    Article  PubMed  CAS  Google Scholar 

  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Eng J Med 329: 1456–1462

    Google Scholar 

  • Maschio G, Alberti D, Janin G et al. (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The angiotensin-convertingenzyme inhibition in progressive renal insufficiency study group. N Engl J Med 334: 939–945

    Google Scholar 

  • Mitch WE, Goldberg AL (1996) Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335: 1897–1905

    Google Scholar 

  • Lewis EJ, Hunsicker LG, Clarke WR et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851–860

    Article  PubMed  CAS  Google Scholar 

  • Sunder-Plassmann G, Hod WH (1997) Erythropoietin and iron. Clin Nephrol 47: 141–157

    PubMed  CAS  Google Scholar 

  • The NESP Guidelines Group (2001) Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant 16 (Suppl 3): 22–28

    Google Scholar 

  • Bargman JM (1999) Management of minimal lesion glomerulo-nephritis: evidence based recommendations. Kidney Int 55 (S70): S3 - S16

    Article  Google Scholar 

  • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, the RENAAL Study Investigators (2001) Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med 345: 861–869

    CAS  Google Scholar 

  • Couser W (1993) Mediation of immune glomerular injury. Clin Investig 71: 808–811

    Article  PubMed  CAS  Google Scholar 

  • Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC (1999) The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. The Mayo Nephrology Collaborative Group. J Am Soc Nephrol 10: 1772–1777

    Google Scholar 

  • Ibrahim HN, Hostetter TH (1997) Diabetic nephropathy. J Am Soc Nephrol 8: 487–493

    PubMed  CAS  Google Scholar 

  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin converting enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329: 1456–1462

    Google Scholar 

  • Muirhead N (1999) Management of idiopathic membranous nephropathy: evidence based recommendations. Kidney Int 55 (S70): S47 - S55

    Article  Google Scholar 

  • Nolin L, Courteau M (1999) Management of IgA nephropathy: evi- dence based recommendations. Kidney Int 55 (S70): S56 - S62

    Article  Google Scholar 

  • Ruggenenti P, Remuzzi G (2000) The role of protein traffic in the progression of renal diseases. Annu Rev Med 51: 315–327

    Article  PubMed  CAS  Google Scholar 

  • The EUCLID Study Group (1997) Randomized placebo controlled trial of lisinopril in normotensive patients with insulin dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 349: 1787–1792

    Article  Google Scholar 

  • Cotran RS, Kumar V, Collins T (eds) (1998) Robbins pathologic basis of disease, 6th edn. W.B. Saunders, Philadelphia

    Google Scholar 

  • Bacon PA (1994) Therapy of vasculitis [editorial]. J Rheumatol 21: 788–790

    PubMed  CAS  Google Scholar 

  • Calabrese LH, Duna GF (1996) Drug-induced vasculitis. Curr Opin Rheumatol 8: 34–40

    Article  PubMed  CAS  Google Scholar 

  • Calabrese LH, Duna GF, Lie JT (1997) Vasculitis in the central nervous system. Arthritis Rheum 40: 1189–1201

    PubMed  CAS  Google Scholar 

  • Chan TM, Li FK, Tang CS et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343: 1156–1162

    Google Scholar 

  • Floege J, Feehally J (2000) IgA nephropathy: recent developments. J Am Soc Nephrol 11: 2395–2403

    PubMed  CAS  Google Scholar 

  • Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187–192

    Google Scholar 

  • Jennette JC, Falk RJ (1994) The pathology of vasculitis involving the kidney. Am J Kidney Dis 24: 130–141

    PubMed  CAS  Google Scholar 

  • Jennette JC, Falk RJ (1998) Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 13 [Suppl 1]: 16–20

    Article  PubMed  Google Scholar 

  • Kallenberg CG, Heeringa P (1998) Pathogenesis of vasculitis. Lupus 7: 280–284

    Article  PubMed  CAS  Google Scholar 

  • Lhote F, Guillevin L (1995) Polyarteriitis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum Dis Clin North Am 21: 911–947

    Google Scholar 

  • Savige J, Davies D, Falk RJ, Jennette JC, Wiik A (2000) Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 57: 846–862

    Article  PubMed  CAS  Google Scholar 

  • Batuman V, Maesaka JK, Haddad B, Tepper E, Landy E, Wedeen PP (1981) The role of lead in gout nephropathy. New Engl J Med 304: 520–523

    Article  PubMed  CAS  Google Scholar 

  • Elseviers MM, DeSchepper A, Corthouts R et al. (1995) High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 48: 1316–1323

    Article  PubMed  CAS  Google Scholar 

  • Gault MM, Barrett BJ (1998) Analgesic nephropathy. In depth review. Am J Kidney Dis 32: 351–360

    Google Scholar 

  • Markowitz GS, Radhakrsihnan J, Kambham N, Valeri AM, Hines WH, DAgati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11: 1439–1448

    PubMed  CAS  Google Scholar 

  • Michielsen P, DeSchepper P (2001) Trend of analgesic nephropathy in two high–endemic regions with different legislation. J Am Soc Nephrol 12: 550–556

    PubMed  CAS  Google Scholar 

  • Pommer W, Molzahn M (1996) Die Analgetikanephropathie. Internist 37: 1129–1136

    PubMed  CAS  Google Scholar 

  • Rossert J, Fishier EA (2000) Acute interstitial nephritis. In: Johnson RJ, Feehally J (Hrsg) Comprehensive clinical nephrology. Mosby, St. Louis. pp 62.1–62. 8

    Google Scholar 

  • Buffing KA, Hoppes P, Blend D, Cugino A, Jarjoura D, Whittier FC (1994) Eosinophils in urine revisited. Clin Nephrol 41: 163–166

    Google Scholar 

  • Sanchez-Fructuoso AI, Torralbo A, Arroyo M et al. (1996) Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant 11: 1775–1780

    Article  PubMed  CAS  Google Scholar 

  • Schlöndorf D, Segerer S (1996) Die akute medikamenteninduzierte tubulointerstitielle Nephritis. Internist 37: 1084–1091

    Google Scholar 

  • Timmer RT, Sands JM (1999) Lithium intoxication. J Am Soc Nephrol 10: 666–674

    PubMed  CAS  Google Scholar 

  • Wrenger E, Bahlmann J, Floege J (1996) Harnsäure und tubulointerstitielle Nierenerkrankung. Internist 37: 1137–1140

    PubMed  CAS  Google Scholar 

  • Zeier M, Ritz E (1996) Hanta-Virus induziertes akutes Nierenversagen. Internist 37: 1092–1095

    PubMed  CAS  Google Scholar 

  • Berufsverband Medizinische Genetik e.V. (1989) Richtlinien zur Durchführung molekulargenetischer diagnostischer Leistungen. Med Genetik 1: 4

    Google Scholar 

  • Kommission für Öffentlichkeitsarbeit und ethische Fragen der Gesellschaft für Humangenetik e.V. (1991) Stellungnahme zur postnatalen prädiktiven genetischen Diagnostik. Med Genetik 3: 10–12

    Google Scholar 

  • Kommission für Öffentlichkeitsarbeit und ethische Fragen der Gesellschaft für Humangenetik e.V. (1992) Stellungnahme zur vorgeburtlichen Diagnostik und zum Schwangerschaftsabbruch. Med Genetik 4: 12

    Google Scholar 

  • Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13: 388–393

    PubMed  CAS  Google Scholar 

  • Brass H, Bergner R, Uppenkamp M, Franz H (2002) Gichtniere–Uratnephropathie. Nieren-und Hochdruckkrankheiten 31: 484–488

    Google Scholar 

  • Klahr S (2001) Obstructive nephropathy. In: Massry SG, Classock RJ (eds) Textbook of nephrology, 4th edn. Lippincott, Williams and Wilkins, Philadelphia

    Google Scholar 

  • Thüroff J, Schulte-Wissermann H (2000) Kinderurologie in Klinik und Praxis. Thieme, Stuttgart New York

    Google Scholar 

  • Walsh P, Retik A, Stamey T, Darracott E (1992) Campbell’s Urology, 6th edn. W.B. Saunders, Philadelphia

    Google Scholar 

  • Zippel RM (2002) Tumorlysesyndrom, tubuläre Obstruktion, Cis- platin. Nieren-und Hochdruckkrankheiten 31: 484–488

    Google Scholar 

  • Mann JFE, Allenberg JR, Luft FC (1997) Renovascular hypertension. In: Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E (eds) Oxford Textbook of clinical nephrology, 2nd edn. Oxford University Press, Oxford, pp 2096–2117

    Google Scholar 

  • Plouin PF, Guery B, La Batide Alanore A (2000) Atherosclerotic renal artery stenosis: surgery, PTA, or medical therapy? Curr Hypertens Res 2: 482–489

    Article  CAS  Google Scholar 

  • Radermacher J, Chavan A, Bleck J et al. (2001) Use of doppler ultrasonography to predict outcome of therapy for renal artery stenosis. New Engl J Med 344: 410–417

    Article  PubMed  CAS  Google Scholar 

  • Ritz E, Mann JFE (2000) Renal angioplasty for lowering blood pressure. New Engl J Med 342: 1042–1043

    Article  PubMed  CAS  Google Scholar 

  • Safian RD, Textor SC (2001) Renal artery stenosis. New Engl J Med 344: 431–442

    Article  PubMed  CAS  Google Scholar 

  • van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Schalekamp MA (2000) The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. New Engl J Med 342: 1007–1014

    Article  PubMed  Google Scholar 

  • Alken P, Bastian HP, Chaussy C et al. (1986) In: Hautmann R, Lutzeyer W (Hrsg) Harnsteinfibel, 2. erw. Auflage. Deutscher Ärzteverlag, Köln, S 29–30

    Google Scholar 

  • Altwein JE, Marberger M (1982) In: Hohenfellner R, Zingg EJ (Hrsg) Urologie in Klinik und Praxis, Bd II. Thieme, Stuttgart, S 744–748

    Google Scholar 

  • Hübner WA, Irby P, Stoller ML (1995) Der kleine Harnstein: natürlicher Verlauf und aktuelle Behandlungskonzepte. Wien Med Wschr 145: 276–279

    PubMed  Google Scholar 

  • Hofbauer J, Ludvik G, Grbovic M, Marberger M (1995) Stellenwert und künftige Entwicklung in der nicht invasiven Behandlung von Harnsteinen mit der extrakorporalen Stoßwellenlithotripsie ( ESWL ). Wien Med Wschr 145: 254–258

    Google Scholar 

  • Hofbauer J, Tuerk C, Höbarth K, Hasun R, Marberger M (1993) ESWL in situ or ureteroscopy for ureteric stones? World J Urol 11: 54–58

    Article  PubMed  CAS  Google Scholar 

  • Wong MYC (2001) An update on percutaneous nephrolithotomy in the management of urinary calculi. Curr Opin Urol 11: 367–372

    Article  PubMed  CAS  Google Scholar 

  • Marberger M, Hofbauer J, Türk C, Höbarth K, Albrecht (1994)

    Google Scholar 

  • Management of ureteroc stones. Eur Urol 25:265–272

    Google Scholar 

  • Painter DJ, Keeley FX Jr (2001) New concepts in the treatment of ureteral calculi. Curr Opin Urol 11: 373–378

    Article  PubMed  CAS  Google Scholar 

  • Norman RW (2001) Metabolic evaluation of stone disease pa- tients: a practical approach. Curr Opin Urol 11: 347–351

    Article  PubMed  CAS  Google Scholar 

  • Höbarth K, Hofbauer J, Szabo N (1994) Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44: 20–25

    Article  PubMed  Google Scholar 

  • Pak CYC (1999) Medical prevention of renal stone disease. Nephron 81: 60–65

    Article  PubMed  CAS  Google Scholar 

  • Dretler SP (1998) The physiologic approach to the medical management of stone disease. Urol Clin North Am 25: 613–623

    Article  PubMed  CAS  Google Scholar 

  • Hofbauer J, Höbarth K, Ludvik G, Marberger M (1994) The ‘Stone Clinic Effect’: myth of reality? Eur Urol 26: 309–313

    PubMed  CAS  Google Scholar 

  • Clark WR, Henderson LW (2001) Renal versus continuous versus intermittent therapies for removal of uremic toxins. Kidney Int 59 [Suppl 78]: 5298–5303

    Google Scholar 

  • Daugirdas JT, Blake PG, Ing TS (2001) Handbook of dialysis, 3rd edn. Lippincott Williams * Wilkins, Philadelphia

    Google Scholar 

  • Eknoyan G, Levin NW, Eschbach JW, Golper TA, Owen WF Jr, Schwab S, Steinberg EP (2001) Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation’s Dialysis Outcomes Quality Initiative. Am J Kidney Dis 37: 179–194

    Google Scholar 

  • Felten H, Kuhlmann MK, Riegel W, Kühn K (1999) Adäquate Dialysebehandlung bei Hämodialyse-and Peritonealdialyse-Patienten. Internist 40: 22–36

    Article  PubMed  CAS  Google Scholar 

  • Franz HE, Hörl WH (Hrsg) (1997) Blutreinigungsverfahren. Technik and Klinik. Thieme, Stuttgart New York

    Google Scholar 

  • Gokal R, Khanna R, Krediet RT, Nolph KD (eds) (2000) Textbook of peritoneal dialysis, 2nd edn. Kluwer Academic Publishers, Dordrecht

    Google Scholar 

  • Hakim RM (2000) Clinical implications of biocompatibility in blood purification membranes. Nephrol Dial Transplant 15 [Suppl 2]: 16–20

    Article  PubMed  Google Scholar 

  • Hakim RM, Lazarus JM (1995) Initiation of dialysis. J Am Soc Nephrol 6: 1319–1328

    PubMed  CAS  Google Scholar 

  • Henrich WL (ed) (1999) Principles and practice of dialysis, 2nd edn. Lippincott, Williams * Wilkins, Philadelphia

    Google Scholar 

  • Jacobs C (2000) At which stage of renal failure should dialysis be started? Nephrol Dial Transplant 15: 305–307

    Article  PubMed  CAS  Google Scholar 

  • Levy J (ed) (2000) Oxford handbook of dialysis. Oxford University Press, Oxford

    Google Scholar 

  • Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in no-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (9223): 26–30

    Article  PubMed  CAS  Google Scholar 

  • Samtleben W, Blumenstein M (1999) Indikation und Auswahl der Dialyseverfahren bei akuter und chronischer Niereninsuffizienz einschließlich kontinuierlicher Verfahren. Internist 40: 3–12

    Article  PubMed  CAS  Google Scholar 

  • Schneditz D, Levin NW (2001) Keep your temper: how to avoid heat accumulation in haemodialysis. Nephrol Dial Transplant 16: 7–9

    Article  PubMed  CAS  Google Scholar 

  • Briggs JD (2001) Causes of death after renal transplantation. Nephrol Dial Transplant 16: 1545–1549

    Article  PubMed  CAS  Google Scholar 

  • Cecka JM (2000) The UNOS scientific renal transplant registry. In: Cecka JM, Terasaki PI (eds) Clinical transplants 1999. UCLA Tissue Typing Laboratory, Los Angeles, p 1–21

    Google Scholar 

  • De Mattos AM, Olyaei AJ, Bennett WM (2000) Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 35 (2): 333–346

    Article  PubMed  Google Scholar 

  • Denton MD, Magee CC, Sayegh MH (1999) Immunosuppressive strategies in transplantation. Lancet 353 (9158): 1083–1091

    Article  PubMed  CAS  Google Scholar 

  • Kassiske BL, Ramos EL, Gaston RS et al. (1995) The evaluation of renal transplant candidates: clinical practice guidelines. J Am Soc Nephrol 6: 1–34

    Google Scholar 

  • Patel R, Paya CV (1997) Infections in solid-organ transplant recipients. Clin Microbiol Rev 10 (1): 86–124

    PubMed  CAS  Google Scholar 

  • Penn I (1999) Neoplastic complications of organ transplantation. In: Ginns LC, Cosimi AB, Morris PJ (eds) Transplantation. Blackwell Science, Oxford London Edinburgh, p 770–786

    Google Scholar 

  • Pohanka E (2001) New immunosuppressive drugs: an update. Curr Opin Urol 11 (2): 143–151

    Article  PubMed  CAS  Google Scholar 

  • Tomson CRV (2001) Cardiovascular complications after renal transplantation. In: Morris PJ (ed) Kidney transplantation. Principles and practice, 5th ed. WB Saunders, Philadelphia, p 445–467

    Google Scholar 

  • Franz M, Hörl WH (1999) Common errors in diagnosis and mangement of urinary tract infections. I: Pathophysiology and diagnostic techniques. Nephrol Dial Transplant 14: 2746–2753

    Google Scholar 

  • Franz M, Hörl WH (1999) Common errors in diagnosis and management of urinary tract infections. II: Clinical management. Nephrol Dial Transplant 14: 2754–2762

    Google Scholar 

  • Kim ED, Schaeffer A (1994) Antimicrobial therapy for urinary tract infections. Semin Nephrol 14: 551–569

    PubMed  CAS  Google Scholar 

  • Kunin CM (1994) Urinary tract infections in females. Clin Infect Dis 18: 1–12

    Article  PubMed  CAS  Google Scholar 

  • Meyrier A (1996) Diagnosis and management of renal infections. Curr Opin Nephrol Hypertens 5: 151–157

    Article  PubMed  CAS  Google Scholar 

  • Nicolle LE (1994) Urinary tract infections in adult women. Curr Opin Infect Dis 7: 3–8

    Article  Google Scholar 

  • Atzpodien J, Buer J, Sel S, Janssen J, Oevermann K (1999) Chemoimmuntherapie des fortgeschrittenen Nierenzellkarzinoms. Urologe A 38: 474–478

    Article  PubMed  CAS  Google Scholar 

  • Atzpodien J, Lopez Hanninen E, Kirchner H et al. (1995) Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol 13: 497–501

    PubMed  CAS  Google Scholar 

  • Becker G, Duffner F, Kortmann R, Weinmann M, Grote EH, Bamberg M (1999) Radiosurgery for the treatment of brain metastases in renal cell carcinoma. Anticancer Res 19: 1611–1617

    PubMed  CAS  Google Scholar 

  • Dunn MD, Portis AJ, Naughton C, Shalhav A, McDougall EM, Clayman RV (2000) Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol 164: 1153–1159

    Article  PubMed  CAS  Google Scholar 

  • Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 163: 442–445

    Article  PubMed  CAS  Google Scholar 

  • Filipas D, Fichtner J, Spix C, Black P, Carus W, Hohenfellner R, Thuroff JW (2000) Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long-term outcome in 180 patients. Urology 56: 387–392

    Article  PubMed  CAS  Google Scholar 

  • Flanigan RC, Blumenstein BA, Salmon S (2000) Cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group trial 8949. J Urol 163 (Suppl 4): 154

    Google Scholar 

  • Hafez KS, Novick AC, Campbell SC (1997) Patterns of tumor recurrence and guidelines for follow-up after nephron sparing surgery for sporadic renal cell carcinoma. J Urol 157: 2067–2070

    Article  PubMed  CAS  Google Scholar 

  • Janetschek G, Marberger M (2000) Laparoscopic surgery in urology. Curr Opin Urol 10: 351–357

    Article  PubMed  CAS  Google Scholar 

  • Jeon SH, Chang SG, Kim JI (1999) The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3NOMO renal cell carcinoma. Anticancer Res 19: 5593–5597

    PubMed  CAS  Google Scholar 

  • Kollender Y, Bickels J, Price WM et al. (2000) Metastatic renal cell carcinoma of bone: indications and technique of surgical intervention. J Urol 164: 1505–1508

    Article  PubMed  CAS  Google Scholar 

  • Levy DA, Slaton JW, Swanson DA, Dinney CPN (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159: 1163–1167

    Article  PubMed  CAS  Google Scholar 

  • Lopez Hanninen E, Kirchner H, Atzpodien J (1996) Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Ural 155: 19–25

    Article  Google Scholar 

  • Medical Research Council Renal Cancer Collaborators (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 353: 14–17

    Article  Google Scholar 

  • Motzer RJ, Russo P (2000) Systemic therapy for renal cell carcinoma. J Urol 163: 408–417

    Article  PubMed  CAS  Google Scholar 

  • Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335: 865–875

    Article  PubMed  CAS  Google Scholar 

  • Oevermann K, Buer J, Hoffmann R et al. (2000) Capecitabine in the treatment of metastatic renal cell carcinoma. Br J Cancer 83: 583–587

    Article  PubMed  CAS  Google Scholar 

  • Pantuck AJ, Zisman A, Rauch MK, Bellegrun A (2000) Incidental renal tumors. Urology 56: 190–196

    Article  PubMed  CAS  Google Scholar 

  • Staehler G, Brkovic D (1999) Die chirurgische Therapie des Nierenzellkarzinoms. Urologe A 38: 452–459

    Article  PubMed  CAS  Google Scholar 

  • Yonover PM, Flanigan RC (2000) Should radical nephrectomy be performed in the face of surgically incurable disease? Curr Opin Ural 10: 429–434

    Article  CAS  Google Scholar 

  • Abrams P, Blaivas JG, Stanton SL, Anderson JT (1989) The standardisation of terminology of lower urinary tract function; produced by the International Continence Society Comitee on Standardisation of Terminology. World J Urol 6: 233–245

    Article  Google Scholar 

  • Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S (2000) Urinary incontinence in both sexes: Prevalence rates and impact on quality of life and sexual life. Neurourol Urodynam 19: 259–271

    Google Scholar 

  • Abrams P, Khoury S, Wein A (eds) (1999) Incontinence. Health Publication, Plymouth, UK

    Google Scholar 

  • Weis RM (1998) Urine transport and voiding function and dysfunction. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campell’s Urology. WB Saunders, Philadelphia, pp 837–1154

    Google Scholar 

  • Adrogue HJ, Madias NE (1998) Management of life-threatening acid-base disorders. Second of two parts. N Engl J Med 338: 107–111

    Google Scholar 

  • Adrogue HJ, Madias NE (1998) Management of life-threatening acid-base disorders. First of two parts. N Engl J Med 338: 26–34

    Google Scholar 

  • Fall PJ (2000) A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad Med 107:249–250,253–254,257–258 passim

    Google Scholar 

  • Gluck SL (1998) Acid-base. Lancet 352: 474–479

    Article  CAS  Google Scholar 

  • Kraut JA, Madias NE (2001) Approach to patients with acid-base disorders. Respir Care 46: 392–403

    PubMed  CAS  Google Scholar 

  • Rose BD, Post TW (2001) Clinical physiology of acid-base and electrolyte disorders, 5th edn. McGraw-Hill, New York

    Google Scholar 

Download references

Authors
  1. Walter H. Hörl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wilfred Druml
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander R. Rosenkranz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gert Mayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bruno Watschinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Georg Böhmig
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marianne Haag-Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Friedhelm Hildebrandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matthias Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Georg Schatzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Johannes Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Johann Hofbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Andreas Vychytil
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Joachim Böhler
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Erich Pohanka
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Bruno Watschinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Martina Franz
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Andreas Floth
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. H. Christoph Klingler
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Rainer Oberbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Stephan Madersbacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität, D-93042, Regensburg, Deutschland

    Jürgen Schölmerich

  2. Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle, Deutschland

    Stefan Burdach

  3. Abteilung Hämatologie, Onkologie Klinik I für Innere Medizin, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Deutschland

    Volker Diehl

  4. Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland

    Helmut Drexler

  5. Medizinische Klinik und Poliklinik III, Klinikum Großhadern — Universität München, Marchioninistraße 15, 81377, München, Deutschland

    Wolfgang Hiddemann

  6. Innere Medizin III Klinische Abteilung für Nephrologie und Dialyse, Allgemeines Krankenhaus, Währinger Gürtel 18-20, A-1090, Wien, Österreich

    Walter H. Hörl

  7. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Bezirksklinikum Regensburg, Universitätsstraße 84, 93053, Regensburg, Deutschland

    Helmfried Klein

  8. Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland

    Michael Landthaler

  9. Medizinische Abteilung mit Intensivstation, Konventhospital der Barmherzigen Brüder Linz, Seilerstätte 2, A-4021, Linz, Österreich

    Kurt Lenz

  10. Abteilung für Endokrinologie Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstraße 55, 45147, Essen, Deutschland

    Klaus Mann

  11. Abteilung Gastroenterologie 6 Hepatologie Medizinische Klinik und Poliklinik, Universität Leipzig, Philipp-Rosenthal-Straße 27, 04103, Leipzig, Deutschland

    Joachim Mössner

  12. Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, Franz-Joseph-Strauß-Allee 11, 93042, Regensburg, Deutschland

    Ulf Müller-Ladner

  13. Institut für Klinische Pharmakologie, Inselspital — Universität Bern, Murtenstraße 35, CH-3010, Bern, Schweiz

    Jürg Reichen

  14. Medizinische Universitätsklinik Knappschaftskrankenhaus, Ruhr-Universität Bochum, In der Schornau 23-25, 44892, Bochum, Deutschland

    Wolff Schmiegel

  15. Abt. Gastroenterologie, Hepatologie, Universitätsklinikum Bergmannsheil, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Deutschland

    Wolff Schmiegel

  16. II. Medizinische Klinik und Poliklinik Städtisches Krankenhaus, Christian-Albrechts-Universität Kiel, Chemnitzstraße 33, 24116, Kiel, Deutschland

    Johann Oltmann Schröder

  17. Zentrum für Innere Medizin Medizinische Klinik und Poliklinik II, Justus-Liebig-Universität, Klinikstraße 36, 35385, Gießen, Deutschland

    Werner Seeger

  18. Innere Medizin IV Medizinische Klinik und Poliklinik, Ruprecht-Karls-Universität, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Wolfgang Stremmel

  19. Sektion Infektiologie Medizinische Klinik Campus Virchow Klinikum, Humboldt Universität, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Norbert Suttorp

  20. Klinische Toxikologie, Giftinformation II. Medizinische Klinik und Poliklinik, Johann-Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland

    L. Sacha Weilemann

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hörl, W.H. et al. (2003). Erkrankungen von Niere und Urogenitaltrakt. In: Schölmerich, J., et al. Medizinische Therapie in Klinik und Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12451-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12451-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-12452-9

  • Online ISBN: 978-3-662-12451-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation